Novo Nordisk employs more than 2,000 people in North Carolina and operates three manufacturing facilities for diabetes and obesity medicines in the Research Triangle Region - in Clayton and Durham - and they're now building a 4th facility, a $4.1 billion expansion in Johnston County that will bring 1,000 more jobs.